A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19
Boulware, D., Pullen, M., Bangdiwala, A., Pastick, K., Lofgren, S., Okafor, E., Skipper, C., Nascene, A., Nicol, M., Abassi, M., Engen, N., Cheng, M., LaBar, D., Lother, S., MacKenzie, L., Drobot, G., Marten, N., Zarychanski, R., Kelly, L., Schwartz, I., McDonald, E., Rajasingham, R., Lee, T., & Hullsiek, K. (2020). A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. The New England Journal of Medicine. DOI: 10.1056/NEJMoa2016638. https://www.nejm.org/doi/full/10.1056/NEJMoa2016638
2
5
Contributors are:
Who are from:
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Observational Study of Hydroxychloroquine in Hospitalized Patients with COVID-19